Vorbeck A, Liman W, Fricke M, Peter H H, Schedel I, Deicher H
Z Rheumatol. 1981 Jul-Aug;40(4):171-8.
In addition to the well-known rheumatoid factors or antiglobulins belonging to different immunoglobulin classes, a new type of antiglobulin has been found in serum and synovial fluid from patients with rheumatoid arthritis. 15/20 sera and 6/6 synovial fluids contained serologically active material with a molecular weight of approximately 95.000 Daltons. Using chromatographic and affinity chromatographic methods as well as specific precipitation techniques, the (Fab')2 character of these antiglobulins could be ascertained. These antiglobulins may arise through enzymatic degradation of IgG or monomeric IgM antiglobulins, or may be the product of partial intracellular degradation of phagocytosed immune complexes with subsequent extrusion of such material. An in vitro blocking effect of (Fab')2 type antiglobulins on SCMC or ADCC reactions was not found.
除了属于不同免疫球蛋白类别的众所周知的类风湿因子或抗球蛋白外,在类风湿性关节炎患者的血清和滑液中还发现了一种新型抗球蛋白。20份血清中的15份以及6份滑液中的6份含有血清学活性物质,其分子量约为95,000道尔顿。使用色谱法、亲和色谱法以及特异性沉淀技术,可以确定这些抗球蛋白的(Fab')2特性。这些抗球蛋白可能是通过IgG或单体IgM抗球蛋白的酶促降解产生的,或者可能是吞噬的免疫复合物在细胞内部分降解后此类物质随后挤出的产物。未发现(Fab')2型抗球蛋白对SCMC或ADCC反应有体外阻断作用。